Re:Update on Google’s Secretive Startup Calico Labs
by ggm on Sunday October 22, 2017 @07:13PM
(#15529556)
If I was a company which had placed map()/reduce() at the core of my working logic, and I had emerging machine learning systems (hate the words, but lets go with it) which demonstrated algorithmic ability to tune and select patterns in "things" I would probably say pre- in-vivo drug analysis was a tractable problem: If protein folding is a "thing" then there are probably other "things" about drugs which are tractable to widespread, large scale compute farm logic, which is in the end, about map()/reduce() and the smarts.
In other words, what Calico is doing, is perhaps more 'boring' than people want, but more applicable to what it has -a (french metric) tonne of money, and specific computer science based smarts at scale.
In other words, what Calico is doing, is perhaps more 'boring' than people want, but more applicable to what it has -a (french metric) tonne of money, and specific computer science based smarts at scale.